{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:59:42Z","timestamp":1768877982814,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ejca.2021.07.009","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T05:56:37Z","timestamp":1628229397000},"page":"85-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection"],"prefix":"10.1016","volume":"155","author":[{"given":"Jun-Cheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6731-0703","authenticated-orcid":false,"given":"Jing-Yu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Cong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cai-Ling","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Hai","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing-Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6619-1247","authenticated-orcid":false,"given":"Jinbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Wei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Shan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qun-Fang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2021.07.009_bib1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2021.07.009_bib2","first-page":"571","article-title":"Liver cancer incidence and mortality in China: temporal trends and projections to 2030","volume":"30","author":"Zheng","year":"2018","journal-title":"Chin J Canc Res"},{"key":"10.1016\/j.ejca.2021.07.009_bib3","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1245\/s10434-010-0976-5","article-title":"Surgical resection of high-risk hepatocellular carcinoma: patient selection, preoperative considerations, and operative technique","volume":"17","author":"Truty","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2021.07.009_bib4","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1007\/s11605-019-04363-1","article-title":"Predicting hepatocellular carcinoma recurrence beyond milan criteria after liver resection for solitary hepatocellular carcinoma","volume":"24","author":"Kim","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ejca.2021.07.009_bib5","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejca.2021.07.009_bib6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s11605-015-2849-5","article-title":"The impact of tumor size on long-term survival outcomes after resection of solitary hepatocellular carcinoma: single- institution experience with 2558 patients","volume":"19","author":"Hwang","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ejca.2021.07.009_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.23246","article-title":"Resection of large hepatocellular carcinoma (\u226510 cm): a unique western perspective","volume":"107","author":"Shrager","year":"2013","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2021.07.009_bib8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3892\/mco.2014.304","article-title":"Stereotactic body radiotherapy combined with transarterial chemoembolization for huge (\u226510 cm) hepatocellular carcinomas: a clinical study","volume":"2","author":"Zhong","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.ejca.2021.07.009_bib9","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.3748\/wjg.v21.i13.3970","article-title":"Oxaliplatin and 5-fluorouracil hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma","volume":"21","author":"Li","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejca.2021.07.009_bib10","first-page":"768","article-title":"Efficacy of major hepatectomy for large hepatocellular carcinoma","volume":"56","author":"Miyoshi","year":"2009","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.ejca.2021.07.009_bib11","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s00261-014-0130-0","article-title":"TNM\/Okuda\/Barcelona\/UNOS\/CLIP international multidisciplinary classification of hepatocellular carcinoma: concepts, perspectives, and radiologic implications","volume":"39","author":"Faria","year":"2014","journal-title":"Abdom Imag"},{"key":"10.1016\/j.ejca.2021.07.009_bib12","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/hep.20486","article-title":"Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score","volume":"40","author":"Kudo","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.ejca.2021.07.009_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jamcollsurg.2007.07.031","article-title":"A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma","volume":"206","author":"Cho","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ejca.2021.07.009_bib14","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.3748\/wjg.v20.i15.4141","article-title":"Staging systems of hepatocellular carcinoma: a review of literature","volume":"20","author":"Maida","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejca.2021.07.009_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-0037-1621712","article-title":"Genetic and epigenetic heterogeneity in normal liver homeostasis and its implications for liver disease and hepatocellular cancer","volume":"38","author":"Hlady","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ejca.2021.07.009_bib16","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","article-title":"Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy","volume":"31","author":"Wang","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.07.009_bib17","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1200\/JCO.2005.05.3884","article-title":"Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer","volume":"24","author":"Bochner","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.07.009_bib18","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1200\/JCO.2010.33.1595","article-title":"Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of European randomized clinical trials","volume":"29","author":"Valentini","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2021.07.009_bib19","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1002\/cam4.1787","article-title":"A novel inflammation-based nomogram system to predict survival of patients with hepatocellular carcinoma","volume":"7","author":"Chen","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.ejca.2021.07.009_bib20","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/SLA.0000000000001339","article-title":"Nomograms for pre- and postoperative prediction of long-term survival for patients who underwent hepatectomy for multiple hepatocellular carcinomas","volume":"263","author":"Yang","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2021.07.009_bib21","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.cgh.2017.12.002","article-title":"Nomogram to predict survival of patients with recurrence of hepatocellular carcinoma after surgery","volume":"16","author":"He","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejca.2021.07.009_bib22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1634\/theoncologist.2016-0231","article-title":"Prognostic nomograms stratify survival of patients with hepatocellular carcinoma without portal vein tumor thrombosis after curative resection","volume":"22","author":"Fu","year":"2017","journal-title":"Oncol"},{"key":"10.1016\/j.ejca.2021.07.009_bib23","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1097\/SLA.0000000000000747","article-title":"Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma","volume":"261","author":"Shim","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2021.07.009_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejca.2016.04.011","article-title":"Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma","volume":"62","author":"Li","year":"2016","journal-title":"Eur J Canc"},{"key":"10.1016\/j.ejca.2021.07.009_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000494844","article-title":"Newly proposed ALBI grade and ALBI-T score as tools for assessment of hepatic function and prognosis in hepatocellular carcinoma patients","volume":"8","author":"Hiraoka","year":"2019","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejca.2021.07.009_bib26","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1245\/s10434-020-09214-x","article-title":"Can we reliably identify the pathological outcomes of neoadjuvant chemotherapy in patients with breast cancer? Development and validation of a logistic regression nomogram based on preoperative factors","volume":"28","author":"Zhang","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2021.07.009_bib27","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jhep.2019.02.023","article-title":"Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma","volume":"70","author":"Xu","year":"2019","journal-title":"J Hepatol"},{"issue":"99","key":"10.1016\/j.ejca.2021.07.009_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/136518202760378489","article-title":"The Brisbane 2000 terminology of liver anatomy and resections. HPB 2000; 2:333-339","volume":"4","author":"Pang","year":"2002","journal-title":"HPB"},{"key":"10.1016\/j.ejca.2021.07.009_bib29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/annonc\/mdy510","article-title":"Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Vogel","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2021.07.009_bib30","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1159\/000509424","article-title":"Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition)","volume":"9","author":"Zhou","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejca.2021.07.009_bib31","doi-asserted-by":"crossref","first-page":"e1552","DOI":"10.1634\/theoncologist.2019-0766","article-title":"Novel models predict postsurgical recurrence and overall survival for patients with hepatitis B virus-related solitary hepatocellular carcinoma \u226410 cm and without portal venous tumor thrombus","volume":"25","author":"Wang","year":"2020","journal-title":"Oncol"},{"key":"10.1016\/j.ejca.2021.07.009_bib32","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2021.07.009_bib33","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11427-017-9259-9","article-title":"42,573 cases of hepatectomy in China: a multicenter retrospective investigation","volume":"61","author":"Zhang","year":"2018","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.ejca.2021.07.009_bib34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000367775","article-title":"Survival analysis over 28 Years of 173,378 patients with hepatocellular carcinoma in Japan","volume":"5","author":"Kudo","year":"2016","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ejca.2021.07.009_bib35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1245\/s10434-012-2513-1","article-title":"A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability","volume":"20","author":"Rodr\u00edguez-Per\u00e1lvarez","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2021.07.009_bib36","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jamasurg.2015.4257","article-title":"Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the milan criteria","volume":"151","author":"Lei","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejca.2021.07.009_bib37","doi-asserted-by":"crossref","first-page":"iv238","DOI":"10.1093\/annonc\/mdy308","article-title":"Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"29","author":"Vogel","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2021.07.009_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/SLA.0b013e3181961c16","article-title":"A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma","volume":"249","author":"Zhou","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2021.07.009_bib39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1478-3231.2009.02166.x","article-title":"Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma","volume":"30","author":"Chua","year":"2010","journal-title":"Liver Int"},{"key":"10.1016\/j.ejca.2021.07.009_bib40","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1080\/00365521.2016.1216588","article-title":"Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials","volume":"51","author":"Si","year":"2016","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejca.2021.07.009_bib41","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00000658-199712000-00006","article-title":"Influence of preoperative transarterial lipiodol chemoembolization on resection\u00a0and\u00a0transplantation for hepatocellular carcinoma in patients\u00a0with cirrhosis","volume":"226","author":"Majno","year":"1997","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejca.2021.07.009_bib42","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.hpb.2018.06.1798","article-title":"Preoperative strategies to improve resectability for hepatocellular carcinoma: a systematic review and meta-analysis","volume":"20","author":"Tustumi","year":"2018","journal-title":"HPB"},{"key":"10.1016\/j.ejca.2021.07.009_bib43","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s12072-019-09981-0","article-title":"Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (\u2265\u200910 cm): a multicenter propensity matching analysis","volume":"13","author":"Li","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ejca.2021.07.009_bib44","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1007\/s00330-015-4021-8","article-title":"Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study","volume":"26","author":"Zhang","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejca.2021.07.009_bib45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00595-017-1553-3","article-title":"Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis","volume":"48","author":"Wada","year":"2018","journal-title":"Surg Today"},{"key":"10.1016\/j.ejca.2021.07.009_bib46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.blre.2007.07.003","article-title":"Transfusion-related immunomodulation (TRIM): an update","volume":"21","author":"Vamvakas","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.ejca.2021.07.009_bib47","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1046\/j.1537-2995.1990.30790385527.x","article-title":"Mechanisms of transfusion-induced immunosuppression","volume":"30","author":"Brunson","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/j.ejca.2021.07.009_bib48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jhep.2016.09.008","article-title":"The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma","volume":"66","author":"Pinato","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejca.2021.07.009_bib49","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/bjs.10123","article-title":"Neutrophil to lymphocyte ratio as an indicator of the malignant behaviour of hepatocellular carcinoma","volume":"103","author":"Okamura","year":"2016","journal-title":"Br J Surg"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492100455X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492100455X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:32:37Z","timestamp":1760733157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980492100455X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":49,"alternative-id":["S095980492100455X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2021.07.009","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of prognostic nomograms for single large and huge hepatocellular carcinoma after curative resection","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2021.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}